CLINICAL_TRIALS
trial_result
· 2022-11-03
Clinical Trial Update: Non-inferiority Clinic of Kollagenase® Compared Iruxol® in Treatment of Cutaneous Ulcers [Phase 2, Phase 3]
Summary
Phase 2/3 trial update comparing Kollagenase with Iruxol for treatment of cutaneous ulcers has been suspended.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Azidus Brasil | Conditions: Ulcers | Phase 2, Phase 3 | Status: SUSPENDED